1. Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA). (29th January 2019) Authors: Ghesquieres, H; Chevrier, M; Laadhari, M; Chinot, O; Choquet, S; Moluçon-Chabrot, C; Beauchesne, P; Gressin, R; Morschhauser, F; Schmitt, A; Gyan, E; Hoang-Xuan, K; Nicolas-Virelizier, E; Cassoux, N; Touitou, V; Le Garff-Tavernier, M; Savignoni, A; Turbiez, I; Soumelis, V; Houillier, C Journal: Annals of oncology Issue: Volume 30:Number 4(2019) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P14.118 Carboxypeptidase G2 (CPG2) rescue after high dose methotrexate (hdMTX) chemotherapy for Primary CNS Lymphoma (PCNSL). A French LOC network study. (6th September 2019) Authors: Garcilazo, Y J; Soussain, C; Tabouret, E; Ahle, G; Schimitt, A; Waultier, A; Blonski, M; Liou-Schischmanoff, A; Hoang-Xuan, K; Houillier, C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P14.45 Primary diffuse large B-cell CNS lymphoma over 80 years: an analysis of 110 patients from the french Oculo-Cerebral Lymphoma (LOC) network. (6th September 2019) Authors: MAAREK, A; Maucort-Boulch, D; Houillier, C; Hoang-Xuan, K; Soussain, C; Ghesquières, H Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P14.48 Extracerebral relapses of primary CNS lymphoma (PCNSL): a LOC network retrospective study. (9th September 2021) Authors: Dufour, J; Choquet, S; Schmitt, A; Ahle, G; Houot, R; Taillandier, L; Ursu, R; Hoang-Xuan, K; Soussain, C; Houillier, C Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P14.73 Toxicity and outcomes of reduced-dose whole brain radiotherapy as consolidation treatment for patients with CNS lymphoma in real life setting. (6th September 2019) Authors: Lesueur, P; Damaj, G; Hoang-Xuan, K; Rolland, V; Schmitt, A; Chinot, O; Fabbro, M; Agapé, P; Chabrot, C; Chebrek, S; Feuvret, L; Stefan, D; Soussain, C; Houillier, C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reply to the letter to the editor 'Maintenance lenalidomide in primary CNS lymphoma' by Rubenstein et al. (16th May 2019) Authors: Ghesquieres, H; Soussain, C Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗